Interestingly, for two cohorts of HNSCC patients treated with anti-PD-1/PD-L1 inhibitors, never-smokers have higher clinical benefit than current/former smokers [90,115]. The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.